This suggests that B7‐H3 may be an immune checkpoint for NPC and serve to inhibit the antitumor effect of 4‐1BB, which further clarifies the mechanism by which B7‐H3 promotes tumor growth. The gene discussed is CD276; the disease is nasopharyngeal carcinoma.